U.S. markets closed
  • S&P 500

    3,638.35
    +8.70 (+0.24%)
     
  • Dow 30

    29,910.37
    +37.87 (+0.13%)
     
  • Nasdaq

    12,205.85
    +111.45 (+0.92%)
     
  • Russell 2000

    1,855.27
    +10.25 (+0.56%)
     
  • Crude Oil

    45.52
    -0.01 (-0.02%)
     
  • Gold

    1,790.70
    +2.60 (+0.15%)
     
  • Silver

    22.77
    +0.14 (+0.60%)
     
  • EUR/USD

    1.1963
    +0.0050 (+0.42%)
     
  • 10-Yr Bond

    0.8420
    -0.0360 (-4.10%)
     
  • GBP/USD

    1.3334
    -0.0022 (-0.17%)
     
  • USD/JPY

    103.9700
    -0.2800 (-0.27%)
     
  • BTC-USD

    18,251.54
    +483.48 (+2.72%)
     
  • CMC Crypto 200

    333.27
    -4.23 (-1.25%)
     
  • FTSE 100

    6,367.58
    +4.65 (+0.07%)
     
  • Nikkei 225

    26,644.71
    +107.41 (+0.40%)
     

Insulet: 3Q Earnings Snapshot

·1 min read

ACTON, Mass. (AP) _ Insulet Corp. (PODD) on Wednesday reported third-quarter profit of $11.6 million.

On a per-share basis, the Acton, Massachusetts-based company said it had profit of 17 cents.

The results exceeded Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of 6 cents per share.

The maker of insulin infusion systems posted revenue of $234 million in the period, also beating Street forecasts. Nine analysts surveyed by Zacks expected $221.1 million.

Insulet shares have risen 35% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $231.43, an increase of 59% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PODD at https://www.zacks.com/ap/PODD